|
|
In the News
Innovation Pays Off At Edwards Lifesciences
Investor’s Business Daily published an article on June 10, 2011 following an interview with Edwards' Chairman and CEO, Michael A. Mussallem. The article focuses on products such as the SAPIEN transcatheter heart valve and GlucoClear glucose in-hospital monitoring system as evidence of the company’s innovations that support its growth. | |  | | | | | New Heart Valve Trial
Edwards' Chairman and CEO, Michael A. Mussallem, appears on CNBC’s “Squawk on the Street” on April 4, 2011 talking about the results of a clinical trial regarding the company’s transcatheter heart valve. | | video
 | | | | | Money in Medical Devices
Edwards' Chairman and CEO, Michael A. Mussallem, appears on CNBC’s “Squawk on the Street” on January 11, 2011 talking about the company’s transcatheter heart valve. | | video
 | | | | |
News Archive
Pivotal Year
In an article published on January 2, 2011, Edwards' Chairman and CEO, Michael A. Mussallem, was named 2010 Businessperson of the Year by the Orange County Business Journal. | |  | | | | | Promise of New Valve Driving Edwards
The Orange County Business Journal published an article on May 16, 2010 following an interview with Edwards' Chairman and CEO, Michael A. Mussallem. The article highlights Edwards' transcatheter heart valves and the company's lead as it enters the U.S. market with approval expected in 2011. | | | | | | | Keep the Heart of Innovation Pumping
On May 23, 2010, the Orange County Register published an article regarding health care reform and the tax that will be imposed on medical device manufacturers. This opinion piece is the result of an interview (video on the right) with Edwards' Chairman and CEO, Michael A. Mussallem, which was published on May 19, 2010. | | video
 | | | | | Recent Trends in Hemodynamic Monitoring
Edwards Lifesciences was featured in the February 2010 issue of Medtech Insight in an article about the latest trends in hemodynamic monitoring. The article focuses heavily on Edwards' advancements in critical care technologies, including the company's FloTrac and continual glucose monitoring systems. | |  | | | | | |
|
|
|
|
|
 |
|
|
|